Encrypted login | home

Program Information

Three Dimensional Dosimetry


L Schreiner
no image available
S Ceberg

T Juang

G Ibbott





LJ Schreiner1*, S Ceberg2*, T Juang3*, G Ibbott4*, (1) Cancer Center of Southeastern Ontario, Kingston, ON, (2) Lund University, Lund, SE, (3) Stanford Cancer Center, Stanford, CA, (4) UT MD Anderson Cancer Center, Houston, TX

Presentations

8:30 AM : 3D Dosimetry in the Clinic: Background and Motivation - L Schreiner, Presenting Author
8:45 AM : 3D Dosimetry in the Clinic: Motion Interplay Effects in Dynamic Radiotherapy - S Ceberg, Presenting Author
9:00 AM : 3D Dosimetry in the Clinic: Validating Special Techniques - T Juang, Presenting Author
9:15 AM : 3D Dosimetry in end-to-end dosimetry QA - G Ibbott, Presenting Author

MO-B-BRB-0 (Monday, August 1, 2016) 8:30 AM - 9:30 AM Room: Ballroom B


Full three-dimensional (3D) dosimetry using volumetric chemical dosimeters probed by 3D imaging systems has long been a promising technique for the radiation therapy clinic, since it provides a unique methodology for dose measurements in the volume irradiated using complex conformal delivery techniques such as IMRT and VMAT. To date true 3D dosimetry is still not widely practiced in the community; it has been confined to centres of specialized expertise especially for quality assurance or commissioning roles where other dosimetry techniques are difficult to implement. The potential for improved clinical applicability has been advanced considerably in the last decade by the development of improved 3D dosimeters (e.g., radiochromic plastics, radiochromic gel dosimeters and normoxic polymer gel systems) and by improved readout protocols using optical computed tomography or magnetic resonance imaging.
In this session, established users of some current 3D chemical dosimeters will briefly review the current status of 3D dosimetry, describe several dosimeters and their appropriate imaging for dose readout, present workflow procedures required for good dosimetry, and analyze some limitations for applications in select settings. We will review the application of 3D dosimetry to various clinical situations describing how 3D approaches can complement other dose delivery validation approaches already available in the clinic. The applications presented will be selected to inform attendees of the unique features provided by full 3D techniques.

Learning Objectives:

1. L. John Schreiner: Background and Motivation
i. Understand recent developments enabling clinically practical 3D dosimetry,
ii. Appreciate 3D dosimetry workflow and dosimetry procedures, and
iii. Observe select examples from the clinic.

2. Sofie Ceberg: Application to dynamic radiotherapy
i. Observe full dosimetry under dynamic radiotherapy during respiratory motion, and
ii. Understand how the measurement of high resolution dose data in an irradiated volume can help understand interplay effects during TomoTherapy or VMAT.

3. Titania Juang: Special techniques in the clinic and research
i. Understand the potential for 3D dosimetry in validating dose accumulation in deformable systems, and
ii. Observe the benefits of high resolution measurements for precision therapy in SRS and in MicroSBRT for small animal irradiators

4. Geoffrey S. Ibbott: 3D Dosimetry in end-to-end dosimetry QA
i. Understand the potential for 3D dosimetry for end-to-end radiation therapy process validation in the in-house and external credentialing setting.


Funding Support, Disclosures, and Conflict of Interest: Canadian Institutes of Health Research; L. Schreiner, Modus QA, London, ON, Canada; T. Juang, NIH R01CA100835

Handouts


Contact Email: